A core cross-linked polymeric micellar platium(IV) prodrug with enhanced anticancer efficiency.

A core cross-linked polymeric micellar cisplatin(IV) conjugate prodrug is prepared by attaching the cisplatin(IV) to mPEG-b-PLL biodegradable copolymers to form micellar nanoparticles that can disintegrate to release the active anticancer agent cisplatin(II) in a mild reducing environment. Moreover, in vitro studies show that this cisplatin(IV) conjugate prodrug displays enhanced cytotoxicity against HepG2 cancer cells compared with cisplatin(II). Further studies demonstrate that the high cellular uptake and platinum-DNA adduct of this cisplatin(IV) conjugate prodrug can induce more cancer-cell apoptosis than cisplatin(II), which is responsible for its enhanced anticancer activity.

[1]  X. Jing,et al.  Facile preparation of core cross-linked micelles from catechol-containing amphiphilic triblock copolymer , 2012 .

[2]  X. Jing,et al.  Biodegradable copolymers with identical cationic segments and their performance in siRNA delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[3]  X. Jing,et al.  Biodegradable polymer - cisplatin(IV) conjugate as a pro-drug of cisplatin(II). , 2011, Biomaterials.

[4]  Gaojian Chen,et al.  Thiol-yne and thiol-ene "click" chemistry as a tool for a variety of platinum drug delivery carriers, from statistical copolymers to crosslinked micelles. , 2011, Biomacromolecules.

[5]  Cornelus F. van Nostrum,et al.  Covalently cross-linked amphiphilic block copolymer micelles , 2011 .

[6]  R. Langer,et al.  Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy , 2010, Proceedings of the National Academy of Sciences.

[7]  P. de Souza,et al.  Core-cross-linked micelles synthesized by clicking bifunctional Pt(IV) anticancer drugs to isocyanates. , 2010, Biomacromolecules.

[8]  Liangfang Zhang,et al.  Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery. , 2010, ACS nano.

[9]  H. Burt,et al.  Polymeric drug delivery of platinum-based anticancer agents. , 2009, Journal of pharmaceutical sciences.

[10]  H. Maeda,et al.  Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  M. Jakupec,et al.  Novel di- and tetracarboxylatoplatinum(IV) complexes. Synthesis, characterization, cytotoxic activity, and DNA platination. , 2007, Journal of medicinal chemistry.

[12]  Craig J Hawker,et al.  Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. , 2006, Chemical Society reviews.

[13]  M. Galanski,et al.  An Entry to Novel Platinum Complexes: Carboxylation of Dihydroxoplatinum(IV) Complexes with Succinic Anhydride and Subsequent Derivatization , 2006 .

[14]  Xiao-ling Fang,et al.  Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123 , 2006, Acta Pharmacologica Sinica.

[15]  W. Buchberger,et al.  Application of HPLC-ICP-MS to speciation of cisplatin and its degradation products in water containing different chloride concentrations and in human urine , 2003 .

[16]  M. Hall,et al.  Platinum(IV) antitumour compounds: their bioinorganic chemistry , 2002 .

[17]  S. Korsmeyer,et al.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. , 2001, Molecular cell.

[18]  H. Maeda.  The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.

[19]  N. Farrell,et al.  Kinetics and mechanism for reduction of anticancer-active tetrachloroam(m)ine platinum(IV) compounds by glutathione , 2000, Journal of Biological Inorganic Chemistry.

[20]  Karen L. Wooley,et al.  Shell crosslinked polymer assemblies: Nanoscale constructs inspired from biological systems , 2000 .

[21]  S. Lippard,et al.  Structure, Recognition, and Processing of Cisplatin-DNA Adducts. , 1999, Chemical reviews.

[22]  S. Korsmeyer,et al.  Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death* , 1999, The Journal of Biological Chemistry.

[23]  John Calvin Reed,et al.  Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.

[24]  Sunhee Choi,et al.  Reduction and Anticancer Activity of Platinum(IV) Complexes , 1998 .

[25]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[26]  T. Shi,et al.  Kinetics and Mechanism for Reduction of trans-Dichlorotetracyanoplatinate(IV) by Thioglycolic Acid, L-Cysteine, D,L-Penicillamine, and Glutathione in Aqueous Solution , 1996 .

[27]  M. McKeage,et al.  Comparative Adverse Effect Profiles of Platinum Drugs , 1995, Drug safety.

[28]  C. Giandomenico,et al.  Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes. An Entr.acte.ee into Orally Active Platinum(IV) Antitumor Agents. , 1995, Inorganic chemistry.

[29]  N. Hadjiliadis,et al.  Complex compounds of platinum (II) and (IV) with amino acids, peptides and their derivatives , 1994 .

[30]  M. Christian,et al.  New Cisplatin Analogues in Development , 1993, Drugs.

[31]  A. Eastman.  Glutathione-mediated activation of anticancer platinum(IV) complexes. , 1987, Biochemical pharmacology.

[32]  L. Davis,et al.  Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies , 1984, Cancer.

[33]  J. Trosko,et al.  Platinum Compounds: a New Class of Potent Antitumour Agents , 1969, Nature.

[34]  Jean-François Gohy,et al.  Block copolymer micelles , 2005 .

[35]  K. Lemma,et al.  Kinetics and mechanism for reduction of oral anticancer platinum(IV) dicarboxylate compounds by L-ascorbate ions , 2000 .

[36]  M. McKeage,et al.  Quantitative determination of platinum complexes in human plasma generated from the oral antitumour drug JM216 using directly coupled high-performance liquid chromatography-inductively coupled plasma mass spectrometry without desolvation , 1999 .

[37]  Atsushi Harada,et al.  Formation of Polyion Complex Micelles in an Aqueous Milieu from a Pair of Oppositely-Charged Block Copolymers with Poly(ethylene glycol) Segments , 1995 .